The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

Advances in inflammasome biology are helping researchers address key selectivity and safety challenges in drug development.

Bionic Biologics represent a novel therapeutic modality that integrates principles of biologic and synthetic design. This innovative platform enables the targeting of well-validated yet previously ...

Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...

While humanized animal models are relatively new to drug development compared to their non-humanized counterparts, they are critical tools in the landscape of biologic drug development. Their success ...

Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities, and ...

School of Pharmacy, Fudan University, Pudong, Shanghai, China. Over the past decade, research advances, infrastructure and ecosystem improvements and drug regulatory system reforms have boosted the ...

Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), announced today the operational readiness of its new aseptic drug product filling line in Stein (CH).

aProximate TM PTCs maintain high expression of key transporters involved in drug handling, including megalin and cubilin, making them ideal for studying drug transporters and drug interactions with ...

The MarketWatch News Department was not involved in the creation of this content. CAMBRIDGE, Mass., Dec. 17, 2025 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company providing ...